Sebelius Kathleen

Sebelius Kathleen is listed in filings as Director at Humacyte, Inc.. This profile follows SEC Form 4 activity through May 20, 2026, including purchase activity and sale activity. Recent filings connect the profile to Humacyte, Inc. (HUMAW), Humacyte, Inc. (HUMA), and Exact Sciences Corporation (EXAS). The current snapshot covers public activity from Jun 17, 2024 to May 20, 2026. Reported amounts are shown as $50.0K to $66.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.